ES2084808T3 - Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas. - Google Patents
Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas.Info
- Publication number
- ES2084808T3 ES2084808T3 ES91903316T ES91903316T ES2084808T3 ES 2084808 T3 ES2084808 T3 ES 2084808T3 ES 91903316 T ES91903316 T ES 91903316T ES 91903316 T ES91903316 T ES 91903316T ES 2084808 T3 ES2084808 T3 ES 2084808T3
- Authority
- ES
- Spain
- Prior art keywords
- alpha
- radical
- compositions
- dermatological
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/002—Aftershave preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE UN FOSFATO DE ALFA-TOCOFEROL, EN PARTICULAR BAJO SU FORMA DL O D, O UNO DE SUS ESTERES, DE FORMULA (I), EN LA QUE: R1 REPRESENTA UN ATOMO DE HIDROGENO, UN RADICAL ALQUILO QUE TIENE DE 1 A 4 ATOMOS DE CARBONO, TAL COMO EN PARTICULAR EL RADICAL METILO O ETILO, O UN RADICAL ALFA-TOCOFERILO; R2 REPRESENTA UN ATOMO DE HIDROGENO, UN RADICAL ALQUILO QUE TIENE DE 1 A 4 ATOMO DE CARBONO, TAL COMO EN PARTICULAR UN RADICAL METILO O ETILO, O UNA CADENA OXIETILENADA, DE FORMULA (II), EN LA QUE R3 Y R4 REPRESENTAN INDEPENDIENTEMENTE UN ATOMO DE HIDROGENO O UN RADICAL METILO, Y N REPRESENTA UN NUMERO ENTERO SUPERIOR O IGUAL A 1; O UNA DE SUS SALES, PARA LA PREPARACION DE UNA COMPOSICION FARMACEUTICA, DERMATOLOGICA O COSMETICA, DESTINADA A LA PREVENCION O AL TRATAMIENTO DE LAS MANIFESTACIONES ALERGICAS, TALES COMO LA ALERGIA CUTANEA O EL ASMA BRONQUITICO, O INFLAMATORIAS, O TAMBIEN A LA PREVENCION O AL TRATAMIENTO DE LOS EFECTOS NOCIVOS DE LOS RADICALESLIBRES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9001143A FR2657526B1 (fr) | 1990-01-31 | 1990-01-31 | Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2084808T3 true ES2084808T3 (es) | 1996-05-16 |
Family
ID=9393284
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91903316T Expired - Lifetime ES2084808T3 (es) | 1990-01-31 | 1991-01-30 | Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas. |
ES94116721T Expired - Lifetime ES2114645T3 (es) | 1990-01-31 | 1991-01-30 | Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94116721T Expired - Lifetime ES2114645T3 (es) | 1990-01-31 | 1991-01-30 | Utilizacion de un fosfato de alfa-tocoferol, o de uno de sus derivados para la preparacion de una composicion cosmetica, dermatologica o farmaceutica, de actividad anti-radicalar; composicion asi obtenida. |
Country Status (11)
Country | Link |
---|---|
US (3) | US5387579A (es) |
EP (2) | EP0513104B1 (es) |
JP (1) | JP3186763B2 (es) |
AT (1) | ATE132370T1 (es) |
CA (1) | CA2075201C (es) |
DE (2) | DE69116135T2 (es) |
DK (1) | DK0513104T3 (es) |
ES (2) | ES2084808T3 (es) |
FR (1) | FR2657526B1 (es) |
GR (1) | GR3019341T3 (es) |
WO (1) | WO1991011189A1 (es) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2657526B1 (fr) * | 1990-01-31 | 1994-10-28 | Lvmh Rech | Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues. |
FR2679904A1 (fr) * | 1991-08-01 | 1993-02-05 | Lvmh Rech | Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues. |
US5643597A (en) * | 1991-08-01 | 1997-07-01 | Lvmh Recherche | Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
KR950007045B1 (ko) * | 1992-04-14 | 1995-06-30 | 주식회사태평양 | 폴리에톡실레이티드 비타민 e를 함유한 피부화장료 |
US5350775A (en) * | 1992-07-20 | 1994-09-27 | Showa Denko K.K. | Benzopyran derivative, method for producing the same and use thereof |
CA2179940A1 (en) * | 1995-07-18 | 1997-01-19 | Kazumi Ogata | Antiallergic composition comprising a phosphoric diester compound |
FR2747044B1 (fr) * | 1996-04-03 | 1998-06-26 | Coletica | Utilisation de graines de vegetaux apres germination comme source de superoxyde dismutase et compositions cosmetiques, pharmaceutiques ou agroalimentaires contenant une telle superoxyde dismutase vegetale, et procede d'extraction |
FR2754713B1 (fr) | 1996-10-22 | 1999-01-08 | Roc Sa | Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques |
US6022867A (en) * | 1996-11-27 | 2000-02-08 | Showa Denko Kabushiki Kaisha | Method of administering vitamin E to animals and compositions containing tocopheryl phosphates and salts thereof for animals |
US6458373B1 (en) * | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
DE19713368A1 (de) * | 1997-03-29 | 1998-10-01 | Beiersdorf Ag | Zubereitungen mit oxidationsempfindlichen Wirkstoffen |
US7030155B2 (en) * | 1998-06-05 | 2006-04-18 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
US6716451B1 (en) * | 1999-11-30 | 2004-04-06 | Soft Gel Technologies, Inc. | Formulation and delivery method to enhance antioxidant potency of vitamin E |
BR0115952B1 (pt) * | 2000-11-14 | 2017-10-24 | Vital Health Sciences Pty Ltd | Emulsion composition for therapeutic administration, process for the preparation of a therapeutic formulation and emulsion composition for topical application |
AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
CA2426885C (en) * | 2000-11-14 | 2010-06-29 | Vital Health Sciences Pty Ltd | Complexes of phosphate derivatives |
WO2002043765A2 (en) * | 2000-11-28 | 2002-06-06 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
CN1547475B (zh) * | 2001-07-27 | 2010-12-15 | 生命健康科学有限公司 | 含电子转移试剂的磷酸酯衍生物的皮肤制剂 |
US20040092428A1 (en) * | 2001-11-27 | 2004-05-13 | Hongming Chen | Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof |
IL162213A0 (en) * | 2001-12-03 | 2005-11-20 | Novacea Inc | Pharmaceutical compositions containing active vitamin d compounds |
EP1460995B1 (en) * | 2001-12-13 | 2010-11-10 | Vital Health Sciences Pty Ltd. | Transdermal transport of compounds |
US20030236301A1 (en) * | 2001-12-19 | 2003-12-25 | Bob Sanders | Liposomal delivery of vitamin E based compounds |
WO2003094882A1 (en) * | 2002-05-09 | 2003-11-20 | Showa Denko K.K. | Skin whitening external preparation |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
US7329688B2 (en) * | 2002-12-17 | 2008-02-12 | Soft Gel Technologies, Inc. | Natural vitamin E compositions with superior antioxidant potency |
AU2003296454A1 (en) * | 2002-12-19 | 2004-07-29 | Access Business Group International Llc | Increasing skin cell renewal with water-soluble vitamin e |
US6645514B1 (en) * | 2002-12-19 | 2003-11-11 | Access Business Group International, Llc | Increasing skin cell renewal with water-soluble Vitamin E |
ATE534384T1 (de) * | 2003-01-17 | 2011-12-15 | Vital Health Sciences Pty Ltd | Verbindungen mit proliferationshemmenden eigenschaften |
AU2003901815A0 (en) * | 2003-04-15 | 2003-05-01 | Vital Health Sciences Pty Ltd | Phosphate derivatives |
TWI262798B (en) * | 2003-12-31 | 2006-10-01 | Ind Tech Res Inst | Liposome and drug deliver system |
US20060281716A1 (en) | 2004-03-03 | 2006-12-14 | West Simon M | Alkaloid formulations |
NZ553476A (en) * | 2004-08-03 | 2010-06-25 | Vital Health Sciences Pty Ltd | Carrier for enteral administration |
JP4523388B2 (ja) * | 2004-11-19 | 2010-08-11 | 日本メナード化粧品株式会社 | コラーゲン合成促進剤及び皮膚外用剤 |
US20090239827A1 (en) * | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
JP2008531602A (ja) * | 2005-03-03 | 2008-08-14 | バイタル ヘルス サイエンシズ プロプライアタリー リミティド | 抗癌特性を有する化合物 |
CN101247834B (zh) * | 2005-06-17 | 2013-10-30 | 生命健康科学公司 | 包含一种或多种二-和/或单-(电子转移剂)磷酸酯衍生物或其络合物的载体 |
NZ565049A (en) * | 2005-06-17 | 2012-02-24 | Vital Health Sciences Pty Ltd | A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
FR2891736B1 (fr) * | 2005-10-12 | 2007-11-30 | Gattefosse Sas Soc Par Actions | Excipient comprenant un derive de cires pour la fabrication de formulations topiques cosmetiques |
CA2631653A1 (en) * | 2005-12-23 | 2007-06-28 | Vital Health Sciences Pty Ltd. | Compounds having cytokine modulating properties |
JP4684906B2 (ja) * | 2006-02-09 | 2011-05-18 | 日本メナード化粧品株式会社 | タイトジャンクション形成促進剤 |
US8865228B2 (en) | 2006-02-21 | 2014-10-21 | Mary Kay Inc. | Stable vitamin C compositions |
JP4675801B2 (ja) * | 2006-03-06 | 2011-04-27 | 日本メナード化粧品株式会社 | Ror活性化剤 |
JP4781855B2 (ja) * | 2006-03-08 | 2011-09-28 | 日本メナード化粧品株式会社 | 複合粉体及び当該複合粉体を含有するメイクアップ化粧料 |
JP4675806B2 (ja) * | 2006-03-16 | 2011-04-27 | 日本メナード化粧品株式会社 | アネキシン活性化剤 |
FR2921259B1 (fr) * | 2007-09-26 | 2015-02-13 | Lvmh Rech | Utilisation cosmetique du phosphate de tocopherol comme agent anti-vieillissement de la peau |
US9445975B2 (en) * | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
JP5546809B2 (ja) * | 2009-07-09 | 2014-07-09 | 日本メナード化粧品株式会社 | 乳化化粧料 |
EP2516011B1 (en) * | 2009-12-23 | 2017-07-12 | Phosphagenics Limited | Carrier composition for delivery of a biologically active compound |
US10071030B2 (en) | 2010-02-05 | 2018-09-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
CA2794734C (en) | 2010-03-30 | 2017-12-12 | Phosphagenics Limited | Transdermal delivery patch |
FR2969924B1 (fr) | 2010-12-30 | 2013-11-15 | Lvmh Rech | Composition comprenant un phosphate de tocopherol |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINO-QUINOLINES AS KINASE INHIBITORS |
EP3287138A1 (en) * | 2012-08-23 | 2018-02-28 | Agila Specialties Private Limited | Improved daptomycin injectable formulation |
FR3015247B1 (fr) | 2013-12-20 | 2016-12-23 | Lvmh Rech | Utilisation du phosphate de tocopherol comme agent hydratant |
JP6339376B2 (ja) * | 2014-02-13 | 2018-06-06 | 株式会社ファンケル | 化粧料 |
CN114712308A (zh) | 2015-12-09 | 2022-07-08 | 磷肌酸有限公司 | 药物制剂 |
AU2017381395A1 (en) | 2016-12-21 | 2019-06-20 | Phosphagenics Limited | Process |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4144325A (en) * | 1976-11-10 | 1979-03-13 | Voyt Walter F | Method of and composition for preventing sunburn while affording tanning |
JPS5944375A (ja) * | 1982-09-06 | 1984-03-12 | Senjiyu Seiyaku Kk | α−トコフエロ−ルリン酸エステルの安定な水溶液 |
JPS59219295A (ja) * | 1983-05-30 | 1984-12-10 | Senjiyu Seiyaku Kk | リン酸ジエステルまたはその塩およびそれらの製造法 |
ATE55905T1 (de) * | 1984-03-07 | 1990-09-15 | Roshdy Ismail | Mittel zur behandlung und zum schutz der haut. |
RO89761A2 (ro) * | 1984-03-19 | 1986-07-30 | Institutul Oncologic,Ro | Medicament destinat cresterii imunitatii cu suport celular si tratamentului unor afectiuni maligne si virale |
US4861580A (en) * | 1985-10-15 | 1989-08-29 | The Liposome Company, Inc. | Composition using salt form of organic acid derivative of alpha-tocopheral |
JPS62265299A (ja) * | 1985-12-18 | 1987-11-18 | Senjiyu Seiyaku Kk | α―トコフェロールとウリジンとのリン酸ジエステル,そのハロゲン置換体もしくはこれらの塩およびそれらの製造法 |
JPS62145019A (ja) * | 1985-12-19 | 1987-06-29 | Senjiyu Seiyaku Kk | 抗炎症剤 |
JPS62205091A (ja) * | 1986-03-04 | 1987-09-09 | Senjiyu Seiyaku Kk | 新規なリン酸ジエステルならびにその塩、その製造法およびそれを含有する製剤 |
JP2526059B2 (ja) * | 1987-04-28 | 1996-08-21 | 千寿製薬株式会社 | 抗潰瘍剤 |
WO1989003689A1 (en) * | 1987-10-19 | 1989-05-05 | The Liposome Company, Inc. | Tocopherol-based pharmaceutical systems |
US5198432A (en) * | 1988-01-29 | 1993-03-30 | Center For Innovative Technology | Method of preventing chlorohydrocarbon toxicity using sterol derivatives |
FR2628317B1 (fr) * | 1988-03-09 | 1991-11-08 | Lvmh Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant |
US5100654A (en) * | 1989-04-07 | 1992-03-31 | Yale University | Phosphorylated derivatives of l-dopa and compositions and methods for increasing the melanin content in mammalian skin and hair |
US5516788A (en) * | 1989-06-22 | 1996-05-14 | University Of Bath | Tetrahydroindenoindole compounds useful in the treatment of conditions associated with free radical formation |
FR2657526B1 (fr) * | 1990-01-31 | 1994-10-28 | Lvmh Rech | Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues. |
US5652274A (en) * | 1991-03-01 | 1997-07-29 | Martin; Alain | Therapeutic-wound healing compositions and methods for preparing and using same |
FR2679904A1 (fr) * | 1991-08-01 | 1993-02-05 | Lvmh Rech | Utilisation d'un phosphate de tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, ou pharmaceutiques et compositions ainsi obtenues. |
US5643597A (en) * | 1991-08-01 | 1997-07-01 | Lvmh Recherche | Use of a tocopherol phosphate or one of its derivatives for the preparation of cosmetic or pharmaceutical compositions and compositions so obtained |
-
1990
- 1990-01-31 FR FR9001143A patent/FR2657526B1/fr not_active Expired - Lifetime
-
1991
- 1991-01-30 CA CA002075201A patent/CA2075201C/en not_active Expired - Lifetime
- 1991-01-30 DE DE69116135T patent/DE69116135T2/de not_active Expired - Lifetime
- 1991-01-30 US US07/917,142 patent/US5387579A/en not_active Expired - Lifetime
- 1991-01-30 DE DE69128653T patent/DE69128653T2/de not_active Expired - Lifetime
- 1991-01-30 EP EP91903316A patent/EP0513104B1/fr not_active Expired - Lifetime
- 1991-01-30 DK DK91903316.7T patent/DK0513104T3/da active
- 1991-01-30 EP EP94116721A patent/EP0652010B1/fr not_active Expired - Lifetime
- 1991-01-30 ES ES91903316T patent/ES2084808T3/es not_active Expired - Lifetime
- 1991-01-30 WO PCT/FR1991/000055 patent/WO1991011189A1/fr active IP Right Grant
- 1991-01-30 ES ES94116721T patent/ES2114645T3/es not_active Expired - Lifetime
- 1991-01-30 AT AT91903316T patent/ATE132370T1/de not_active IP Right Cessation
- 1991-01-30 JP JP50377391A patent/JP3186763B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-24 US US08/328,041 patent/US5656618A/en not_active Expired - Lifetime
-
1995
- 1995-05-30 US US08/456,665 patent/US5952001A/en not_active Expired - Lifetime
-
1996
- 1996-03-19 GR GR960400736T patent/GR3019341T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE69128653D1 (de) | 1998-02-12 |
JP3186763B2 (ja) | 2001-07-11 |
FR2657526B1 (fr) | 1994-10-28 |
EP0652010A1 (fr) | 1995-05-10 |
US5387579A (en) | 1995-02-07 |
DK0513104T3 (da) | 1996-05-20 |
US5656618A (en) | 1997-08-12 |
DE69116135D1 (de) | 1996-02-15 |
EP0652010B1 (fr) | 1998-01-07 |
WO1991011189A1 (fr) | 1991-08-08 |
JPH05505393A (ja) | 1993-08-12 |
US5952001A (en) | 1999-09-14 |
ES2114645T3 (es) | 1998-06-01 |
CA2075201C (en) | 2003-12-02 |
EP0513104B1 (fr) | 1996-01-03 |
EP0513104A1 (fr) | 1992-11-19 |
DE69116135T2 (de) | 1996-08-29 |
ATE132370T1 (de) | 1996-01-15 |
GR3019341T3 (en) | 1996-06-30 |
DE69128653T2 (de) | 1998-07-23 |
FR2657526A1 (fr) | 1991-08-02 |
CA2075201A1 (en) | 1991-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2084808T3 (es) | Uso de un fosfato de un alfa-tocoferol, o de uno de sus derivados para la preparacion de composiciones cosmeticas, dermatologicas, o farmaceuticas; composiciones asi obtenidas. | |
ES2126068T3 (es) | Derivados de estilbeno citotoxicos y composicion farmaceutica que los contiene. | |
DE69604714T2 (de) | Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen | |
MX9202287A (es) | Nuevos derivados de perhidroisoindol, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
ES2073889T3 (es) | Composicion despigmentante que contiene unos derivados de arbutosido. | |
DE59710082D1 (de) | Kosmetische Präparate in Form einer Nanodispersion | |
DE69006398T2 (de) | N-substituierte Lauramide, ihre Herstellung und sie enthaltende Zusammensetzungen. | |
MX9202282A (es) | Nuevos derivados de 3-amino piridazinas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
AU6476394A (en) | 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position 11beta, preparation process and intermediates, use as medicaments and pharmaceutical compositions containing them | |
DE69404071T2 (de) | 3-Deoxyoligosacchariden, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
ES2133511T3 (es) | Composicion tintorea que contiene p-fenilendiaminas con azufre, p-fenilendiaminas con azufre y su procedimiento de preparacion. | |
IL96618A0 (en) | Pharmaceutical compositions containing fluoroquinolone derivatives | |
DE69018730D1 (de) | Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
MX9205539A (es) | Nuevos derivados de la 1,8-benzonaftiridina, procedimiento para su preparacion y composiciones que los contienen. | |
ATE147755T1 (de) | Dipeptidderivate und diese als aktive bestandteile enthaltendes prophylaktisches oder therapeutisches mittel gegen knochenkrankheiten | |
NZ246598A (en) | Trazodone derivatives; compounds and preparation, pharmaceutical compositions; intermediate compounds | |
ES2062469T3 (es) | Derivados de amino-acidos sustituidos, procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
GR3003472T3 (en) | 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them | |
DE69011235T2 (de) | Derivate von N-(Vincristinyl-23) und N-(Noranhydro-5-vinblastinyl-23) von Amino-1-methylphosphonsäure, ihre Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
ES2081957T3 (es) | Nuevos derivados sustituidos en posicion 15, de la 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones que los contienen. | |
ES2068685T3 (es) | Procedimiento de preparacion de nuevos derivados de 1,5-diin-cicloalquenos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Grant refused |
Effective date: 19930530 |
|
FG2A | Definitive protection |
Ref document number: 513104 Country of ref document: ES |